ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Innovative genetic, cellular techniques help identify multiple disease targets – Science Daily

Innovative genetic, cellular techniques help identify multiple disease targetsScience DailyResearch released today highlights advances in the use of CRISPR-Cas9 and human induced pluripotent stem cell technologies to identify novel therapeutic targets … Continue reading

2017-11-13 Michael Zand NEWS

Alnylam’s patisiran grabs EMA accelerated review; CRISPR Therapeutics, Casebia enter mRNA deal with CureVac – Endpoints News

Continue reading

2017-11-13 Michael Zand NEWS

Efforts Continue to Expand Immunotherapy in CRC – OncLive

Efforts Continue to Expand Immunotherapy in CRCOncLiveHowever, the overwhelming majority of CRC patients are microsatellite-stable (MSS) and do not tend to respond well to single-agent immunotherapy, noted Johanna Bendell, MD. Researchers are are looki… Continue reading

2017-11-13 Michael Zand NEWS

Immunotherapy Combination Improves Melanoma Outcomes, But at a Cost – Curetoday.com

Targeted OncologyImmunotherapy Combination Improves Melanoma Outcomes, But at a CostCuretoday.comPre-surgical (neoadjuvant) treatment with the immunotherapy combination Opdivo (nivolumab) plus Yervoy (ipilimumab) nearly tripled objective response rates… Continue reading

2017-11-13 Michael Zand NEWS

Strong Evidence Emerging That Gut Microbiome Is a Key Variable in Immunotherapy Efficacy – Medscape

MedscapeStrong Evidence Emerging That Gut Microbiome Is a Key Variable in Immunotherapy EfficacyMedscape"I want to convince you that the microbiome can actually dictate the cancer immune set-point," said Laurence Zitvogel, MD, PhD, group lead… Continue reading

2017-11-13 Michael Zand NEWS

In study inspired by late Stanford physician, immunotherapy found safe in HIV patients – Scope (blog)


FierceBiotech

Alnylam’s patisiran grabs EMA accelerated review; CRISPR Therapeutics, Casebia enter mRNA deal with CureVac
Endpoints News
CRISPR Therapeutics, together with its joint venture Casebia, is teaming up with CureVac to develop improved Cas9 mRNA constructs for in vivo gene editing. CureVac will also take charge of manufacturing all mRNA needed in clinical development and …
BRIEF—New mRNA collaboration for CRISPR, Casebia and CureVacThe Pharma Letter

all 4 news articles »

Continue reading

2017-11-13 Michael Zand NEWS

CRISPR Can Now Edit Genes Using Nanoparticles Instead of Viruses – Motherboard

CRISPR Can Now Edit Genes Using Nanoparticles Instead of VirusesMotherboardSince its was first harnessed by scientists in 2013, the natural gene-editing technology known as CRISPR has sparked a designer baby controversy, dreams of ending hereditary dis… Continue reading

2017-11-13 Michael Zand NEWS

Data from Study of Potential Gene Therapy for Blindness Presented Today – Rare Disease Report

TheCableData from Study of Potential Gene Therapy for Blindness Presented TodayRare Disease ReportAt AAO 2017, the 121st Annual Meeting of the American Academy of Ophthamology, this morning, new research was presented exhibiting that a new gene therapy… Continue reading

2017-11-13 Michael Zand NEWS
  • 1
  • …
  • 901
  • 902
  • 903
  • 904
  • 905
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Scope (blog)

In study inspired by late Stanford physician, immunotherapy found safe in HIV patients
Scope (blog)
And the findings — that it is safe for people with HIV and cancer to receive a type of cancer immunotherapy called a checkpoint inhibitor — are just what Kohrt would have predicted, the study’s senior author Martin “Mac” Cheever, MD, explained in a …